MDMA

Lykos accepts FDA’s view that reviving rejected MDMA therapy’s fortunes requires fresh phase 3 trial
Fierce Biotech
Mon, 10/21/24 - 09:48 am
Lykos Therapeutics
MDMA
FDA
MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD
BioSpace
Mon, 09/30/24 - 09:51 am
Lykos Therapeutics
MDMA
PTSD
psychedelics
Lykos CEO to depart after FDA rejection, layoffs
BioPharma Dive
Thu, 09/5/24 - 10:38 pm
Lykos Therapeutics
Pharma CEOs
FDA
MDMA
Amy Emerson
Lykos co-founder Doblin to step down after MDMA setback
Pharmaphorum
Fri, 08/16/24 - 11:14 am
Lykos Therapeutics
Rick Doblin
MDMA
FDA
Following rejection and retractions, Lykos caps off chaotic week by cutting 75% of staff
Fierce Biotech
Thu, 08/15/24 - 10:08 pm
Lykos Therapeutics
layoffs
MDMA
PTSD
Article retractions muddy MDMA waters after FDA denial
Pharmaphorum
Mon, 08/12/24 - 11:23 am
MDMA
Lykos Therapeutics
PTSD
FDA
psychedelics
Lykos will ask FDA to reconsider its decision following rejection of MDMA therapy for post-traumatic stress disorder
Fierce Biotech
Sun, 08/11/24 - 01:09 pm
Lykos Therapeutics
FDA
MDMA
PTSD
midomafetamine
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
Stat
Fri, 08/9/24 - 11:29 am
FDA
MDMA
psychedelics
Lykos Therapeutics
PTSD
Lykos’ MDMA-Assisted PTSD Therapy Heads to FDA After Adcomm Setback
BioSpace
Mon, 08/5/24 - 11:06 am
Lykos Therapeutics
MDMA
PTSD
FDA
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
Fierce Biotech
Thu, 06/13/24 - 11:09 am
Lykos Therapeutics
FDA
MDMA
PTSD
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive
Tue, 06/4/24 - 11:36 pm
Lykos Therapeutics
FDA
MDMA
psychedelic drugs
FDA panel to review psychedelic drug MDMA for first time
Reuters
Tue, 06/4/24 - 11:40 am
FDA
MDMA
PTSD
psychedelic drugs
Lykos Therapeutics
Psychoactive drugs are having a moment. The FDA will soon weigh in.
Medical Marketing and Media
Wed, 05/29/24 - 11:23 am
FDA
psychoactive drugs
MDMA
ICER Finds ‘Substantial Uncertainties’ in Lykos’ MDMA Trials Ahead of Adcomm
BioSpace
Thu, 05/16/24 - 11:33 am
Lykos Therapeutics
ICER
PTSD
MDMA
FDA advisers to weigh first psychedelic therapy in early June
Fierce Biotech
Tue, 05/7/24 - 11:23 am
Lykos Therapeutics
FDA
MDMA
Lykos
psychedelic drugs
advisory committees
An unusual drugmaker raises north of $100M for ecstasy-based PTSD therapy
BioPharma Dive
Sun, 01/7/24 - 04:06 pm
Lykos Therapeutics
MDMA
FDA
funding
First-ever drug application for MDMA finally reaches FDA after near 40-year journey
Fierce Biotech
Thu, 12/14/23 - 09:51 am
FDA
MDMA
psychedelics
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
Fierce Biotech
Fri, 09/15/23 - 11:43 am
MDMA
MAPS Public Benefit Corp
clinical trials
PTSD
psychedelic drugs
Revive, PharmaTher team up to develop MDMA microneedle patch
Fierce Pharma
Tue, 02/7/23 - 06:44 pm
Revive Therapeutics
PharmaTher
MDMA
microneedle patch

Pages